VAS

DIAGNOSTIC_TEST3 trials

Sponsors

Gilead Sciences, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey, Charite University, Berlin, Germany

Conditions

Alcohol Use DisorderAlcoholismBreast CancerBreast Cancer FemaleLymphedemaLymphedema of Upper LimbMyofascial Pain SyndromeNonalcoholic Fatty Liver Disease (NAFLD)

Phase 2

Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH)

CompletedNCT02781584

Gilead SciencesNonalcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis (NASH)

Start: 2016-06-13End: 2020-12-17Updated: 2022-03-16

Unknown Phase

Myofascial Pain Syndrome in Patients With Breast Cancer-related Lymphedema

CompletedNCT06012786

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyBreast Cancer, Breast Cancer Female, Lymphedema +3

Start: 2023-08-30End: 2025-02-20Updated: 2025-09-12

Effect of Social Isolation on the Role of Pavlovian Mechanisms for Control Over Alcohol Use

Not yet recruitingNCT06256952

Charite University, Berlin, GermanyAlcoholism, Alcohol Use Disorder, Ostracism +2

Start: 2024-10-01End: 2027-06-30Target: 100Updated: 2024-08-28

Related Papers

NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials.

2025-01-019 citations

Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat.

2022-01-0632 citations